A carregar...
Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy
BACKGROUND: The use of methotrexate-acitretin (MTX-ACI) combination therapy in treating psoriasis has been limited due to concerns related to hepatic fibrosis. However, in vitro evidence revealed a protective effect of acitretin in methotrexate (MTX)-induced liver fibrosis. OBJECTIVE: This study aim...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8170124/ https://ncbi.nlm.nih.gov/pubmed/34093007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S304168 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|